JPRN-UMIN000035567
Completed
未知
An exploratory study to evaluate biomarkers of prospective multicenter observational study of atezolizumab in patients with locally advanced or metastatic non-small cell lung cancer :J-TAIL - An exploratory study to evaluate biomarkers of J-TAI
Medical Affairs, CHUGAI PHARMACEUTICAL CO., LTD.0 sites250 target enrollmentJanuary 16, 2019
Conditionson-small cell lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- Medical Affairs, CHUGAI PHARMACEUTICAL CO., LTD.
- Enrollment
- 250
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
An exploratory investigation of the biomarker for senescence and arteriosclerosis in renal transplant donors and recipients.Recipients and donors in living-kidney transplantationJPRN-UMIN000004905Kagawa University, Faculty of Medicine45
Active, not recruiting
Phase 1
Biomarkermoderate-to-severe psoriasisMedDRA version: 19.0 Level: PT Classification code 10037153 Term: Psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2015-002588-40-DEniversity Hospital Schleswig-Holstein40
Not yet recruiting
Not Applicable
A retrospective study to explore the biomarkers in lung cancer immunotherapy, 2nd stage -irAE predictionung cancerJPRN-UMIN000051528ational Cancer Center Hospital East350
Recruiting
Not Applicable
Exploratory analysis of biomarkers predicting the treatment response and the prognosis in patients with gastric carcinomaJPRN-UMIN000036886Sapporo Medical University350
Recruiting
Not Applicable
Exploratory analysis of biomarkers predicting the treatment response and the prognosis in patients with esophageal carcinomaEsophageal cancerJPRN-UMIN000036884Department of Medical Oncology, Sapporo Medical University School of Medicine250